Infectious causation of chronic disease: Examining the relationship between Giardia lamblia infection and irritable bowel syndrome

World Journal of Gastroenterology

Volumn 13, Issue 34, 2007, Pages 4574-4578

  Penrose, Alice S ^a   Wells, Eden V ^b   Aiello, Allison E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

Author keywords

Foodborne; Gastrointestinal; Giardia lamblia; Irritable bowel syndrome; Parasite; Prescription; Refugees

Indexed keywords

ALOSETRON; DICYCLOVERINE; TEGASEROD;

ADULT; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; FEMALE; GIARDIA LAMBLIA; HOSPITAL ADMISSION; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCRIPTION; PREVALENCE; PROTOZOAL INFECTION; REFUGEE; UNITED STATES;

EID: 34648834789     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i34.4574     Document Type: Article

References (23)

1. Ortega YR, Adam RD. Giardia: overview and update. Clin Infect Dis 1997; 25: 545-549; quiz 550
2. Kucik CJ, Martin GL, Sortor BV. Common intestinal parasites. Am Fam Physician 2004; 69: 1161-1168
3. Hlavsa MC, Watson JC, Beach MJ. Giardiasis surveillance-United States, 1998-2002. MMWR Surveill Summ 2005; 54: 9-16
4. U.S. Food and Drug Administration. Giardia lamblia. In: The bad bug book foodborne pathogenic microorganisms and natural toxins handbook. Washington. 1992. Available from: URL: www.cfsan.fda.gov/~mow/ chap22.html
5. CDC. Notifiable diseases/deaths in selected cities weekly information. Morbidity and Mortality Weekly Report 2006; 45: 1320-1330
6. Feldman M, Scharschmidt BF, Sleisenger NIH. Gastroinestinal and liver disease. 6th ed. Philadelphia: WB Saunders Company, 1998:1537
7. Bujanda L, Gutierrez-Stampa MA, Caballeros CH, Alkiza ME. Gastrointestinal disorders in Guatemala and their relation with parasitic infections An Med Interna 2002; 19: 179-182
8. Grazioli B, Matera G, Laratta C, Schipani G, Guarnieri G, Spiniello E, Imeneo M, Amorosi A, Foca A, Luzza F. Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol 2006; 12: 1941-1944
9. Sanchez RC, Navarro Cano G. Diagnostic value of limited research in patients with irritable bowel syndrome. Rev Gastroenterol Mex 2004; 69: 24-29
10. D'Anchino M, Orlando D, De Feudis L. Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect 2002; 45: 169-172
11. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin infect Dis 2006; 43: 898-901
12. Gomez-Escudero O, Schmulson-Wasserman MJ, Valdovinos-Diaz MA. Post-infectious irritable bowel syndrome. A review based on current evidence. Rev Gastroenterol Mex 2003; 68: 55-61
13. Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, Taki I, Norris JM, Erlich HA, Eisenbarth GS, Rewers M. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101: 2333-2340
14. Nayak AK, Karnad DR, Abraham P, Mistry FP. Metronidazole relieves symptoms in irritable bowel syndrome: the confusion with so-called 'chronic amebiasis'. Indian J Gastroenterol 1997; 16: 137-139
15. Dear KL, Elia M, Hunter JO. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome? Dig Dis Sci 2005; 50: 758-766
16. Bolin TD, Davis AE, Duncombe VM. A prospective study of persistent diarrhoea. Aust N Z J Med 1982; 12: 22-26
17. Sinha P, Ghoshal UC, Choudhuri G, Naik S, Ayyagari A, Naik SR. Does Entamoeba histolytica cause irritable bowel syndrome? Indian J Gastroenterol 1997; 16: 130-133
18. Lagace-Wiens PR, VanCaeseele PG, Koschik C. Dientamoeba fragilis: an emerging role in intestinal disease. CMAJ 2006; 175: 468-469
19. Giacometti A, Cirioni 0, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999; 18: 436-439
20. Hussain R, Jaferi W, Zuberi S, Baqai R, Abrar N, Ahmed A, Zaman V. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg 1997; 56: 301-306
21. Yakoob J, Jafri W, Jafri N, Islam M, Asim Beg M. In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome. Br J Biomed Sci 2004; 61: 75-77
22. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131: 445-450; quiz 660
23. Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98-104